207 related articles for article (PubMed ID: 32696320)
1. Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database.
Kamath A; Maity N; Nayak MA
Clin Drug Investig; 2020 Sep; 40(9):883-889. PubMed ID: 32696320
[TBL] [Abstract][Full Text] [Related]
2. Signals and trends of Guillain-Barré syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems.
Lee H; Kim HJ; Choe YJ; Shin JY
Vaccine; 2020 Jul; 38(34):5464-5473. PubMed ID: 32600907
[TBL] [Abstract][Full Text] [Related]
3. Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System.
Bardenheier BH; Duderstadt SK; Engler RJ; McNeil MM
Vaccine; 2016 Aug; 34(37):4406-14. PubMed ID: 27449076
[TBL] [Abstract][Full Text] [Related]
4. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
Martin D; Menschik D; Bryant-Genevier M; Ball R
Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
[TBL] [Abstract][Full Text] [Related]
5. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
[TBL] [Abstract][Full Text] [Related]
6. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome.
Miller ER; McNeil MM; Moro PL; Duffy J; Su JR
Vaccine; 2020 Nov; 38(47):7458-7463. PubMed ID: 33039207
[TBL] [Abstract][Full Text] [Related]
7. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
8. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
Haber P; Moro PL; Ng C; Dores GM; Lewis P; Cano M
Vaccine; 2019 Mar; 37(11):1516-1520. PubMed ID: 30739795
[TBL] [Abstract][Full Text] [Related]
9. Hearing disorder following COVID-19 vaccination: A pharmacovigilance analysis using the Vaccine Adverse Event Reporting System.
Chen C; Fu F; Ding L; Xiao J
J Clin Pharm Ther; 2022 Nov; 47(11):1789-1795. PubMed ID: 36089844
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome following influenza vaccination.
Haber P; DeStefano F; Angulo FJ; Iskander J; Shadomy SV; Weintraub E; Chen RT
JAMA; 2004 Nov; 292(20):2478-81. PubMed ID: 15562126
[TBL] [Abstract][Full Text] [Related]
11. Influenza vaccination and Guillain Barre syndrome.
Geier MR; Geier DA; Zahalsky AC
Clin Immunol; 2003 May; 107(2):116-21. PubMed ID: 12763480
[TBL] [Abstract][Full Text] [Related]
12. Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system.
Luo C; Jiang Y; Du J; Tong J; Huang J; Lo Re V; Ellenberg SS; Poland GA; Tao C; Chen Y
Pharmacoepidemiol Drug Saf; 2021 May; 30(5):602-609. PubMed ID: 33533072
[TBL] [Abstract][Full Text] [Related]
13. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
14. A study of the association between seasonal influenza vaccines and the increased risk of Guillain-Barré syndrome using Vaccine Adverse Event Reporting System, 2018-2019.
Fujimori M; Hasegawa S; Sasaoka S; Iguchi K; Nakamura M
Pharmazie; 2021 Sep; 76(9):437-443. PubMed ID: 34481535
[TBL] [Abstract][Full Text] [Related]
15. Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database.
Sato K; Mano T; Niimi Y; Toda T; Iwata A; Iwatsubo T
Int J Infect Dis; 2021 Oct; 111():310-312. PubMed ID: 34492394
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
17. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; DeStefano F; Iskander JK; Haber P; Chen RT;
Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):505-10. PubMed ID: 15317028
[TBL] [Abstract][Full Text] [Related]
18. Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.
Woo EJ; Moro PL
Vaccine; 2021 Mar; 39(13):1812-1817. PubMed ID: 33678452
[TBL] [Abstract][Full Text] [Related]
19. Association between seasonal influenza vaccines and the increased risk of acute disseminated encephalomyelitis, estimated using the Vaccine Adverse Event Reporting System.
Fujimori M; Nakamura M
Pharmazie; 2022 Sep; 77(7):262-269. PubMed ID: 36199182
[TBL] [Abstract][Full Text] [Related]
20. Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014.
Haber P; Moro PL; Cano M; Lewis P; Stewart B; Shimabukuro TT
Vaccine; 2015 Apr; 33(16):1987-92. PubMed ID: 25678241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
